Glaukos GKOS Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| Corneal Health | $86.37M+7.7% | $80.21M+3.3% | $77.67M+13.2% | $68.62M+10.6% | |
| Glaucoma | $421.07M+38.8% | $303.28M+27.9% | $237.04M+10.6% | $214.24M-7.6% | |
| Revenue by Geography | |||||
| Non Us | $132.4M+16.8% | $113.39M+19.0% | $95.32M+19.7% | $79.62M+13.4% | |
| US | $375.04M+38.9% | $270.09M+23.1% | $219.4M+8.0% | $203.24M-9.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Glaukos break its business down?
- Glaukos (GKOS) reports revenue by product across 2 parts — Corneal Health and Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Glaukos's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Glaukos's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
